171 filings
6-K
GNFT
Genfit
17 Jun 24
Current report (foreign)
4:10pm
6-K
GNFT
Genfit
10 Jun 24
Current report (foreign)
5:59pm
6-K
GNFT
Genfit
29 May 24
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
4:10pm
6-K
GNFT
Genfit
22 May 24
Current report (foreign)
12:06pm
6-K
GNFT
Genfit
14 May 24
GENFIT Reports First Quarter 2024 Financial Information
4:10pm
6-K
j7bej0
25 Apr 24
Current report (foreign)
4:10pm
6-K
2dozw
15 Apr 24
Current report (foreign)
4:10pm
6-K
o674ebcl n91c
5 Apr 24
GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F
2:03pm
6-K
euyays0mtc s2
4 Apr 24
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
4:45pm
6-K
lh1mb9v
29 Feb 24
Current report (foreign)
4:10pm
SC 13G/A
r6xmjd8
14 Feb 24
Genfit / TANG CAPITAL PARTNERS ownership change
4:00pm
6-K
9gous1m 70rfauq4
17 Jan 24
GENFIT Announces 2024 Financial Calendar
6:00am
6-K
b170pc
11 Jan 24
Current report (foreign)
4:10pm
6-K
g12c8d
8 Dec 23
Current report (foreign)
8:00am
6-K
w4e4vwakne qyx517
7 Dec 23
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
6:37am
6-K
e5o71pc4hca8ue
6 Dec 23
Current report (foreign)
11:30am
6-K
oqotody8cug
16 Nov 23
GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
4:10pm
6-K
xjhm pbduz5n2a1pr7c
13 Nov 23
Current report (foreign)
4:30pm
6-K
gq1 tsjbtvqxpc
9 Nov 23
GENFIT Reports Third Quarter 2023 Financial Information
4:10pm